| Name | QL-1200186 |
|---|
| Description | QL-1200186 is anorally activeand selective inhibitor ofTYK2. Oral administration of QL-1200186, dose-dependently inhibitsinterferon-γ(IFNγ) production afterinterleukin-12(IL-12) challenge and significantly ameliorates skin lesions in psoriatic mice[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C26H27N7O3 |
|---|---|
| Molecular Weight | 485.54 |